The Secretary of Foreign Relations Marcelo Ebrard, reported through his Twitter account that the doses of CansinoBio Vaccine arrived in Mexico to be applied immediately.
Through his official Twitter account, the Secretary of Foreign Affairs, Marcelo Ebrard, reported the arrival in Mexico of a Chinese vaccine against covid-19 to be applied to 15 thousand volunteers immediately, this as part of phase 3 of this project .
At around 10:14 p.m. on November 11, the doses of Chinese vaccine against covid-19 arrived in Mexico to be applied to 15 thousand volunteers, as indicated by Marcelo Ebrard, who shared some photographs of the arrival of this preparation in the country.
The search for the vaccine to stop the coronavirus continues and the tests do not stop, in Mexico 15 thousand volunteers will test the Chinese vaccine that is in phase 3, hoping that they will be favorable results against this virus.
You can see: Pair of scientists develop Pfizer BioNTech vaccine against Covid-19.
The head of the Ministry of Foreign Affairs explained through his Twitter account that 7,000 units of the CansinoBio vaccine project have arrived in Mexico to be applied immediately in the country to the volunteers who will help in this phase.
7000 units of the CansinoBio vaccine project arrive to be applied immediately in phase 3 in Mexico with 15 thousand volunteers. Special recognition for the professionalism and accuracy with which they act. Hope is being translated into reality against Covid-19
In addition, he pointed out that with the arrival of this vaccine and the participation of Mexico in its phase 3, it is a step towards the hope of a cure for the coronavirus that has strongly attacked the country’s citizens and medical personnel.
Also, Marcelo Ebrard reported that 140 million dollars will be invested in this phase 3 to test the Chinese vaccine from Cansino Biologics, with the participation of 15 thousand volunteers, with 7 thousand units of this preparation that will be applied immediately.
This vaccine will be applied to the 15 thousand volunteers to observe the reactions before its effectiveness is determined, as well as the Pfizer vaccine, which announced to give favorable results with 90% immunity.